Skip to main content
. 2020 Feb 19;11(9):2679–2687. doi: 10.7150/jca.40974

Figure 5.

Figure 5

IL22 promotes tumor growth via miR-181 upregulation in CM xenograft models. (A, B) Tumor growth in different CM xenograft models under IL22 and ad-sh-miR-181 treatment. (C) Expression of miR-181 in tumor tissues from different CM xenograft models. *P<0.05 verse control group, #P<0.05 verse IL22 group.